HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Gandhi Selected Research

eprenetapopt

10/2022Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Gandhi Research Topics

Disease

2Neoplasms (Cancer)
10/2022 - 01/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 01/2017
1Nausea
10/2022
1Dizziness (Lightheadedness)
10/2022
1Vomiting
10/2022
1Necrosis
03/2000

Drug/Important Bio-Agent (IBA)

2B7-H1 AntigenIBA
10/2022 - 01/2017
2pembrolizumabIBA
10/2022 - 01/2017
1Cisplatin (Platino)FDA LinkGeneric
10/2022
1eprenetapoptIBA
10/2022
1Interleukin-1 (Interleukin 1)IBA
03/2000
1NF-kappa B (NF-kB)IBA
03/2000

Therapy/Procedure

2Therapeutics
10/2022 - 01/2017
2Drug Therapy (Chemotherapy)
10/2022 - 01/2017